# EDGAR Filing Document

**Accession Number:** 0001471420
**File Stem:** 0001193125-25-145546
**Filing Date:** 2025-6
**Character Count:** 6373
**Document Hash:** 79d22cb17b66be6834b6203c494bd093
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-145546.hdr.sgml**: 20250624

**ACCESSION NUMBER**: 0001193125-25-145546

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250624

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20250624

**DATE AS OF CHANGE**: 20250624

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Columbia Seligman Premium Technology Growth Fund, Inc.
- **CENTRAL INDEX KEY:** 0001471420

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 811-22328
- **FILM NUMBER:** 251067895

**BUSINESS ADDRESS:**
- **STREET 1:** 290 CONGRESS STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 612-671-4321

**MAIL ADDRESS:**
- **STREET 1:** 290 CONGRESS STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Seligman Premium Technology Growth Fund, Inc.
- **DATE OF NAME CHANGE:** 20090901

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 24, 2025

### Columbia Seligman Premium Technology Growth Fund, Inc.
(Exact name of registrant as specified in its charter)

MARYLAND 811-22328 20-0994125 <br> (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

290 Congress Street, Boston, Massachusetts 02210 <br> (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (800)-937-5449

NOT APPLICABLE

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;**Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| &nbsp;&nbsp;&nbsp; Common Stock | STK | The New York Stock Exchange |

---

---

| | |
|:---|:---|
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |  |
| Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |

---

------

SECTION 7 — REGULATION FD

#### Item 7.01 Regulation FD Disclosure.
Registrant is furnishing as Exhibit 99.1 the attached Press Release dated June 24, 2025 for Columbia Seligman Premium Technology Growth Fund, Inc.

------

#### Exhibit Index

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 99.1 | [Press Release](d23880dex991.htm) |
|  104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 24, 2025

---

| | |
|:---|:---|
| COLUMBIA SELIGMAN PREMIUM<br> TECHNOLOGY GROWTH FUND, INC. | COLUMBIA SELIGMAN PREMIUM<br> TECHNOLOGY GROWTH FUND, INC. |
| By: | /s/ Joseph D'Alessandro |
|  | Joseph D'Alessandro |
|  | Assistant Secretary |

---

## Exhibit 99.1

**Exhibit 99.1** 

---

| | |
|:---|:---|
| Stockholder contact: | salesinquiries@columbiathreadneedle.com |
| Media contact: | Meghan Shields<br> meghan.shields@columbiathreadneedle.com |

---

**COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC.** 

**HOLDS 15<sup>TH</sup> ANNUAL MEETING OF STOCKHOLDERS** 

**MINNEAPOLIS, MN, June 24, 2025** — Columbia Seligman Premium Technology Growth Fund, Inc. (the "Fund") (NYSE: **STK**) today held its 15<sup>th</sup> Annual Meeting of Stockholders (the "Meeting") in Minneapolis, Minnesota. Stockholders voted in favor of the recommendations of the Fund's Board of Directors (the "Board") on each of two proposals at the Meeting.

Specifically, Stockholders re-elected Directors Daniel J. Beckman, Janet Langford Carrig, Douglas A. Hacker, and Sandra L. Yeager, each for a term that will expire at the Fund's 2028 Annual Meeting of Stockholders, and all until their successors are elected and qualify. Stockholders also ratified the Board's selection of PricewaterhouseCoopers LLP as the Fund's independent registered public accounting firm for the 2025 fiscal year.

The Fund is managed by Columbia Management Investment Advisers, LLC.

**Investors should consider the investment objectives, risks, charges, and expenses of the Fund carefully before investing. A prospectus containing information about the Fund (including its investment objectives, risks, charges, expenses, and other information about the Fund) may be obtained by contacting your financial advisor or visiting www.columbiathreadneedleus.com. The prospectus should be read carefully before investing in the Fund. For more information, please call 866-666-1532 or visit www.columbiathreadneedleus.com.** 

The Fund is not insured by the FDIC, NCUA or any federal agency, is not a deposit or obligation of, or guaranteed by any financial institution, and involves investment risks including possible loss of principal and fluctuation in value.© 2025 Columbia Threadneedle. All rights reserved.

AdTrax CTNA-8096991.1-RUSH